Renaissance Technologies’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $584K | Sell |
224,600
-96,900
| -30% | -$252K | ﹤0.01% | 2759 |
|
2025
Q1 | $611K | Buy |
321,500
+42,900
| +15% | +$81.5K | ﹤0.01% | 2659 |
|
2024
Q4 | $404K | Buy |
278,600
+56,000
| +25% | +$81.2K | ﹤0.01% | 2947 |
|
2024
Q3 | $410K | Buy |
222,600
+82,000
| +58% | +$151K | ﹤0.01% | 2865 |
|
2024
Q2 | $141K | Buy |
140,600
+70,200
| +100% | +$70.2K | ﹤0.01% | 3119 |
|
2024
Q1 | $139K | Sell |
70,400
-106,399
| -60% | -$210K | ﹤0.01% | 3302 |
|
2023
Q4 | $276K | Buy |
176,799
+149,999
| +560% | +$234K | ﹤0.01% | 3016 |
|
2023
Q3 | $53K | Buy |
+26,800
| New | +$53K | ﹤0.01% | 3392 |
|
2023
Q2 | – | Sell |
-52,300
| Closed | -$171K | – | 3958 |
|
2023
Q1 | $171K | Buy |
52,300
+400
| +0.8% | +$1.31K | ﹤0.01% | 3336 |
|
2022
Q4 | $261K | Sell |
51,900
-12,315
| -19% | -$61.9K | ﹤0.01% | 3291 |
|
2022
Q3 | $146K | Sell |
64,215
-1,950
| -3% | -$4.43K | ﹤0.01% | 3487 |
|
2022
Q2 | $175K | Buy |
66,165
+52,865
| +397% | +$140K | ﹤0.01% | 3697 |
|
2022
Q1 | $18K | Buy |
+13,300
| New | +$18K | ﹤0.01% | 4011 |
|